Wednesday, January 22, 2025

LANGaware Forges Transformative Collaboration with Premier, Inc.’s PINC AI™ Applied Sciences (PAS) to Revolutionize Healthcare

Related stories

HEAVY.AI Launches Analytics Platform with NVIDIA Grace

Customers of the platform see significant performance and cost...

Omada Teams Up with Microsoft to Integrate AI and IGA

Omada A/S, a global leader in Identity Governance and...

Lumina AI Unveils PrismRCL 2.6.0 with LLM Upgrades

Lumina AI, a pioneering force in CPU-optimized machine learning...

Prompt Security Launches Enhanced GitHub Copilot Solution

Prompt Security, a leader in generative AI (GenAI) security,...

Buck.ai & AccuKnox Partner for Zero Trust Security

AccuKnox, a leading provider of Cloud Native Application Protection...
spot_imgspot_img

Real-world data to support early patient identification for patients with neurodegenerative and behavioral health diseases.

LANGaware, an innovative leader in digital cognitive and behavioral health diagnostics, is announcing that it will partner with Premier’s PINC AI™ Applied Sciences (PAS) to leverage Real-World Data (RWD) for the development of novel therapeutics addressing neurodegenerative and behavioral health diseases.

PAS, renowned for its robust data gleaned from over 4,350 hospitals and 300,000 continuum-of-care providers nationwide, will provide expertise in conducting prospective research utilizing retrospective synthetic arms built from the PINC AI™ Healthcare Database (PHD).

“Neurodegenerative diseases like Alzheimer’s and Parkinson’s and behavioral health conditions such as depression affect millions of people worldwide,” said Denise Juliano, Group Vice President of Life Sciences at PINC AI™ Applied Sciences. “The PAS-LANGaware partnership will enable RWD that supports early patient identification and detection – and drives evidence-based decisions by clinicians to improve quality, lower costs, reduce risk and help ensure safety for these patients.”

Also Read: Enhatch Announces FDA Clearance for a TKA Patient Specific Instrumentation System with AI-Assisted Segmentation and Treatment Planning

LANGaware, known for its AI-driven precision in early detection, aims to extend the availability of its platform to individuals, health systems and life science companies. Through unique voice and language biomarkers, LANGaware’s technology reduces the likelihood of false positives and unnecessary treatments.

“We are thrilled to partner with PAS and extend the reach of our digital assessment tool to more patients, health systems and life science companies,” said Vassiliki Rentoumi, Founder and CEO of LANGaware. “Our goal is to revolutionize early detection of cognitive and mental health diseases, supporting novel therapy development as well as earlier intervention by providers, to improve patient outcomes and drive positive changes in the healthcare industry. We are actively seeking partners that share our commitment to transforming patient care.”

The collaboration signifies a significant step forward in expanding access to advanced diagnostic services across the United States. By combining PAS’ extensive network of health systems and PINC AI’s RWD capabilities with LANGaware‘s cutting-edge technology, the partnership aims to revolutionize healthcare by driving innovation in early detection and treatment.

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img